Raman spectroscopy based molecular signatures of methamphetamine and HIV induced mitochondrial dysfunction

Area of Science:

• Neuroscience
• Cell Biology
• Toxicology

Background:

• Methamphetamine (METH) abuse is a significant public health issue, particularly among HIV-infected individuals.
• HIV Tat protein is known to exacerbate neuroinflammation and neurotoxicity.
• Microglia, the primary immune cells of the central nervous system, are implicated in METH and HIV-related neuropathology.

Purpose of the Study:

• To investigate the molecular and cellular effects of METH and/or HIV Tat on microglial cells.
• To elucidate the role of oxidative stress and mitochondrial dysfunction in METH/HIV Tat-induced neuropathology.
• To explore potential molecular targets for therapeutic intervention.

Main Methods:

• Primary microglial cell cultures were treated with METH and/or HIV Tat.
• Oxidative stress and reactive oxygen species (ROS) levels were measured.
• Mitochondrial respiration and bioenergetics were assessed.
• Changes in protein, lipid, and nucleotide concentrations were analyzed using Raman Spectroscopy.

Main Results:

• METH and/or HIV Tat treatment led to increased oxidative stress and ROS production in microglia.
• Both METH and HIV Tat impaired mitochondrial respiration, causing bioenergetic dysfunction.
• Significant alterations in protein, lipid, and nucleotide concentrations were observed.
• Mitochondrial dysfunction was identified as a critical factor in the observed neuropathology.

Conclusions:

• METH and HIV Tat synergistically induce oxidative stress and mitochondrial dysfunction in microglia.
• These cellular and molecular changes contribute to the neuropathology associated with METH abuse in HIV patients.
• Targeting mitochondrial pathways may offer a therapeutic strategy for METH/HIV-associated neurotoxicity.